Disciplined Investors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-726
Closed -$255K 142
2025
Q4
$255K Sell
726
-178
-20% -$60.2K 0.17% 108
2025
Q3
$292K Hold
904
0.21% 94
2025
Q2
$352K Sell
904
-1
-0.1% -$402 0.27% 77
2025
Q1
$394K Sell
905
-101
-10% -$40.5K 0.36% 65
2024
Q4
$399K Buy
+1,006
New +$421K 0.38% 61

Other funds holding ELV

Disciplined Investors's ELV Position: Q1 2026 in Review

Disciplined Investors sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 726 shares — an estimated $255K sold.

Disciplined Investors first reported a position in ELV in Q4 2024 and held it in 5 quarters. The position peaked at $399K in Q4 2024. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Disciplined Investors reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Disciplined Investors sold 726 Elevance Health shares in Q1 2026, an estimated $255K.
  • Disciplined Investors first reported a position in Elevance Health in Q4 2024 and held it in 5 quarters.
  • Disciplined Investors's Elevance Health position peaked at $399K in Q4 2024.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Disciplined Investors's 13F filing for Q1 2026, filed 12 May 2026.